Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma

  • Laura Tornatore
  • , Daria Capece
  • , Daniel D'Andrea
  • , Federica Begalli
  • , Daniela Verzella
  • , Jason Bennett
  • , Gary Acton
  • , Elizabeth A. Campbell
  • , James Kelly
  • , Michael Tarbit
  • , Nigel Adams
  • , Selina Bannoo
  • , Antonio Leonardi
  • , Annamaria Sandomenico
  • , Domenico Raimondo
  • , Menotti Ruvo
  • , Angela Chambery
  • , Metod Oblak
  • , Magda J. Al-Obaidi
  • , Richard S. Kaczmarski
  • Ian Gabriel

Research output: Contribution to journalLetterpeer-review

15 Citations (Scopus)

Abstract

Despite the recent introduction of new treatments and improvements in clinical outcomes, multiple myeloma (MM) remains a medical problem
Original languageEnglish
Pages (from-to)588-592
Number of pages5
JournalBritish Journal of Haematology
Volume185
Issue number3
Early online date26 Sept 2018
DOIs
Publication statusPublished - May 2019
Externally publishedYes

Bibliographical note

Free access

Keywords

  • NF-kB
  • multiple myeloma
  • clinical trials
  • drug
  • apoptosis
  • NF-κB

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma'. Together they form a unique fingerprint.

Cite this